DMAA Warnings Shed Light On FDA NDI Enforcement
This article was originally published in The Tan Sheet
Executive Summary
FDA’s warning letters to 10 marketers of DMAA-containing products might have a silver lining for the supplement industry as they suggest the agency may be flexible on its controversial interpretation of some provisions in the new dietary ingredient notification requirement.
You may also be interested in...
Weight Loss Products Provide Ample Targets In FDA War On Spiked Supplements
FDA finds four weight loss products that contain potentially dangerous undeclared ingredients, including DMAA and sibutramine. The agency also continues to warn about bee pollen with undeclared ingredients.
Weight Loss Products Provide Ample Targets In FDA War On Spiked Supplements
FDA finds four weight loss products that contain potentially dangerous undeclared ingredients, including DMAA and sibutramine. The agency also continues to warn about bee pollen with undeclared ingredients.
Industry Suggests Increase In Spiked Supplements Reflects FDA Investment In Testing, Targeted Selection
The number of products marketed as supplements and identified as tainted in 2013 grew 136% from 2011 – the year after FDA announced it would take “swift and strong” enforcement action. Trends in recalls and public notifications likely reflect FDA’s investment in testing products, a strategy in need of updating, supplement industry trade groups say.